Выпуск
Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb
Pharmaceutical Executive · 26 октября 2026 г. · 2 мин
Bristol Myers Squibb discloses a patient death in its Phase I CAR-T multiple sclerosis trial, Pathos AI launches multi-year collaborations with Bristol Myers Squibb and Tempus AI to advance Alzheimer’s drug development, and health economist Dr. Nadine Zawadzki speaks with The Ron Lanton Report on how value is defined across healthcare.